Cracking the ‘Black Box’ of Cell Manufacturing for the First Time ! TherapiAI, a leading AI-powered biopharmaceutical innovator, today announced its latest research collaboration with Dr. Kun-Yi Lin, a prominent stem cell expert from Tri-Service General Hospital. The study, recently
Continue Reading
Leading AI pharmaceutical brand TherapiAI is expanding its footprint in Asia! Following a successful entry into the Japanese market, TherapiAI officially launched its strategic expansion into Southeast Asia today (the 24th). The company recently made its regional debut by unveiling
Continue Reading
Bora to discuss a recent collaboration with Therapi AI, highlighting its focus on strengthening operational execution across the biopharma development cycle and supply chain through AI-enabled technologies Bora Pharmaceuticals (TWSE: 6472; OTCQX: BORAY) operates with a differentiated “dual-engine” strategy, combining
Continue Reading
The Investment Dilemma: The “Must-Play” Game of the Era. AI has emerged as the defining strategic priority and a primary target for capital allocation across industries. From pharmaceuticals to retail, companies are aggressively deploying Generative AI and automation at a
Continue Reading
Antibody-Drug Conjugates (ADCs) are among the most promising precision therapies today. By combining the high targeting capability of monoclonal antibodies with the potent cytotoxicity of small-molecule drugs, they have become a new focal point in the R&D of cancer and
Continue Reading
ADC Opportunities and Challenges: High Technical Barriers are the Cornerstone of Long-Term CDMO Advantage. For pharmaceutical CDMOs, ADCs present immense commercial opportunities. On one hand, the rapid expansion of global clinical pipelines is driving outsourcing demand. On the other hand,
Continue Reading
Article Categories
Article Categories
Article Categories
Latest Articles
Follow Us
